The role inflammation and infection in pathogenesis atherosclerosis;Úloha infekcie a zápalu v patogenéze aterosklerózy

Vnitrni Lekarstvi

Volumn 48, Issue 7, 2002, Pages 657-666

  Jaber, Jihad ^a   Murin J ^a   Kinova S ^a   Gavornik P ^a   Ghanem Wisam, M A ^a   Radman, A ^a   Gharaibeh, A ^a   Richter, P ^a  

^a I Interna Klinika   (Slovakia)

Author keywords

Antibiotics; Atherosclerosis; Cardiovascular events; Chlamydia pneumoniae; Infection; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; ANGIOTENSIN; CHOLESTEROL; FIBRINOGEN; GAMMA INTERFERON; HEAT SHOCK PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPROTEIN A; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNITY; CHLAMYDOPHILA PNEUMONIAE; DIABETES MELLITUS; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; GENETIC PREDISPOSITION; HELICOBACTER PYLORI; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNE RESPONSE; INFECTION; INFLAMMATION; OBESITY; PATHOGENESIS; REVIEW; RISK FACTOR; SMOKING; T LYMPHOCYTE; ANIMAL; ARTERIOSCLEROSIS; BACTERIAL INFECTION; BLOOD VESSEL; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ARTERIOSCLEROSIS; BACTERIAL INFECTIONS; BLOOD VESSELS; HUMANS; INFLAMMATION;

EID: 17544386412     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection
2. Chlamydia infections and heart disease linked through antigenic mimicry
3. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk
4. Leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
5. Chronic infections and coronary heart disease: Is there a link?
6. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis
7. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
8. Tumor necrosis factor C-reactive protein and prostaglandin E2 in patients with severe congestive heart failure treated with enalapril
9. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo
10. CRP and complement are important mediators of tissue damage in acute myocardial infarction
11. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of acute myocardial infarction
12. Chronic infection in the etiology of atherosclerosis - The case for chlamydia pneumoniae
13. Chlamydia pneumoniae: Inflammation and instability of the atherosclerotic plaque
14. Randomised trial of roxithromycin in non-Q-Wave coronary syndromes: ROXIS pilot study
15. Production of c-reactive and risk of coronary events in stable and unstable angina
16. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo
17. Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native artériosclerosis and recurrent stenosis after intervention
18. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis
19. Genetic manipulation of vascular adhesion molecules in mice
20. Induction of macrophage foam cell formation by Chlamydia pneumoniae
21. C-reactive protein and cardiovascular risk: Has the time come for screening the general population?
22. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the Monica ausburg cohort study
23. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression
24. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
25. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by nested polymerase chain reaction (PCR)
26. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
27. Activation of monocyte/macrophage function related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
28. Reduction of atherosclerosis in mice by inhibition of CD40 signaling
29. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke
30. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
31. Antibiotics and risk of subsequent first-time acute myocardial infarction
32. Epitope specificity of antiheat shock protein 65/60 serum antibodies in atherosclerosis
33. Systemic dissemination of C. pneumoniae via macrophages
34. Macrophage infiltration in acute coronary syndroms. Implications for plaque rupture
35. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndroms: A TIMI 11A substudy. Thrombolysis in myocardial infarction
36. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
37. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse
38. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients
39. The renaissance of C-reactive protein
40. Inflammation, aspirin, the risk of cardiovascular disease in apparently healthy men
41. Prospective study of C-rective protein and the risk of futur cardiovascular events amony apparently healthy women
42. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
43. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
44. Infections, inflammation and the risk of coronary heart disease
45. Atherosclerosis - An inflammatory disease
46. Animal models for Chlamydia pneumoniae
47. Ligation of CD40 activates interleukin 1β-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1-beta
48. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction
49. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
50. Treatment of Helicobacter and Chlamydia pneumoniae infections decrease fibrinogen plasma levels in patients with ischaemic heart disease
51. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
52. Relation ship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular health study and the rural Health Promotion project
53. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
54. Statins do more than just lower cholesterol
55. Effects of monotherapy with an HMG-Coa reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Interventional trial
56. Atherosclerosis, autoimmunity, and vascular-associated lymphoid issue
57. CRP in healthy subjects: Association with obesity, insulin resistance and endothelial dysfunction: A potential role for cytokines originating from adipose tissue
58. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients